<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>QUESTION: I often prescribe domperidone to women as a galactagogue starting at a dose of 30 mg and increasing the dose as needed </plain></SENT>
<SENT sid="1" pm="."><plain>In March of this year, Health Canada released an advisory warning of domperidone use and <z:mp ids='MP_0004085'>abnormal heart rhythms</z:mp> and <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="2" pm="?"><plain>Should I cap doses at 30 mg or stop prescribing domperidone <z:hpo ids='HP_0000001'>all</z:hpo> together to these women </plain></SENT>
<SENT sid="3" pm="."><plain>ANSWER: The Health Canada warning is based on 2 studies </plain></SENT>
<SENT sid="4" pm="."><plain>The results of the studies are not directly applicable to breastfeeding and should not change the way you normally manage otherwise healthy breastfeeding women </plain></SENT>
</text></document>